CIK 0000920148
- Large accelerated filer
LABCORP HOLDINGS INC.
Sign in to watch- Ticker
- LH
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 992588107
- Phone
- +1 336-229-1127
- Business address
- 358 S MAIN ST, BURLINGTON, NC, 27215
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,241,708
- in 3 filings, $108K under 10b5-1 plans
Net −$1,241,708. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | Rothman Paul Director | Option exercise | +717 | 717 | ||
| 2024-06-06 | Rothman Paul Director | Option exercise · Restricted Stock Unit | −717 | 944 | ||
| 2024-05-14 | van der Vaart Sandra D EVP, Chief Legal Officer | Sale | −1,800 | $210.83 | $379K | 5,836.98 |
| 2024-05-14 | van der Vaart Sandra D EVP, Chief Legal Officer | Sale | −200 | $210.84 | $42K | 5,636.98 |
| 2024-05-02 | ANDERSON KERRII B Director | Sale | −250 | $200.10 | $50K | 15,722 |
| 2024-04-30 | ANDERSON KERRII B Director | Sale | −250 | $204.14 | $51K | 15,972 |
| 2024-04-30 | EISENBERG GLENN A Chief Financial Officer, EVP | Option exercise | +10,229 | 50,785 | ||
| 2024-04-30 | EISENBERG GLENN A Chief Financial Officer, EVP | Shares withheld for taxes | −4,496 | $201.37 | $905K | 46,289 |
| 2024-04-30 | EISENBERG GLENN A Chief Financial Officer, EVP | Option exercise · Performance Share Unit | −10,229 | 0 | ||
| 2024-04-29 | Wilkinson Peter J SVP, Chief Accounting Officer | Sale | −2,439 | $204.33 | $498K | 2,087.22 |
| 2024-04-15 | EISENBERG GLENN A Chief Financial Officer, EVP | Option exercise | +10,229 | 45,052 | ||
| 2024-04-15 | EISENBERG GLENN A Chief Financial Officer, EVP | Shares withheld for taxes | −4,496 | $203.32 | $914K | 40,556 |
| 2024-04-15 | EISENBERG GLENN A Chief Financial Officer, EVP | Option exercise · Restricted Stock Unit | −10,229 | 5,477 | ||
| 2024-04-01 | Schroeder Mark S EVP, Pres Diagnostics & COO | Sale 10b5-1 | −6,477 | $217.29 | $1.4M | 5,036.14 |
| 2024-04-01 | Summy Amy B. EVP, Chief Marketing Officer | Sale 10b5-1 | −3,500 | $217.29 | $761K | 3,975 |
| 2024-04-01 | Bailey Megan D. EVP, Chief Strategy Officer | Option exercise | +205 | 505 | ||
| 2024-04-01 | Bailey Megan D. EVP, Chief Strategy Officer | Shares withheld for taxes | −69 | $216.35 | $15K | 436 |
| 2024-04-01 | Bailey Megan D. EVP, Chief Strategy Officer | Option exercise · Restricted Stock Unit | −205 | 5,407 | ||
| 2024-03-28 | van der Vaart Sandra D EVP, Chief Legal Officer | Sale 10b5-1 | −3,553 | $216.74 | $770K | 7,636.98 |
| 2024-03-27 | van der Vaart Sandra D EVP, Chief Legal Officer | Option exercise 10b5-1 | +6,158 | 13,794.98 |
Page 25 of 28 · 545 trades